AXIOM (Klaar)
A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
- Middel
- factor Xa
- Populatie
- acuut coronair syndroom
- Fase
- II
- Jaar aanvang
- 2009
A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes